Company Ventures
VC Fund
New York, United States
Company Ventures is an early-stage venture firm that facilitates interactions between peers and delivering a dynamic shared experience. The firm helps businesses of all sizes unlock true value. It was founded in 2018 and headquartered in New York, United States.
- Total investments:
- 182
- Last investment:
- Lead investor:
- 1%
Last updated:
For AI agents: llms.txt
Industries Company Ventures invests in
Stages Company Ventures invests in
Countries Company Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
James Lovey
|
|||
Matthew Harrigan
|
|||
Nelson Schubart
|
|||
Lindsey Seigel
|
|||
Rani Nagpal
|
Investment Focus
Industry
- Software 31 (17%)
- Health Care 30 (16%)
- Artificial Intelligence 19 (10%)
- FinTech 18 (10%)
- Financial Services 18 (10%)
Stage
- Seed 69 (38%)
- Series A 37 (20%)
- Pre-Seed 14 (8%)
- Series B 14 (8%)
- Funding Round 6 (3%)
Country
- United States 102 (56%)
- Canada 1 (1%)
- France 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
James Lovey
VP, Investments & Operations
|
VP, Investments & Operations | Total investments: 0 | Find email | |
|
Matthew Harrigan
Co-Founder, CEO & Managing Director
|
Co-Founder, CEO & Managing Director | Total investments: 2 | Find email | |
|
Nelson Schubart
General Partner
|
General Partner | Total investments: 0 | Find email | |
|
Lindsey Seigel
Head of Impact
|
Head of Impact | Total investments: 0 | Find email | |
|
Rani Nagpal
Mentor
|
Mentor | Total investments: 0 | Find email | |
| See all 6 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Claryx
|
Claryx is building the hospital immune system, reading the genomes of confirmed patient infections, linking related cases as outbreaks, and tracing each back to its likely source. When that source is in the building (a sink, a shared piece of equipment, a particular room), Claryx finds it by matching the patient's strain against a digital twinof the hospital's microbiome, sequenced from its air, its water and its surfaces, all on proprietary chemistry cheap enough to run continuously. Founded by brothers Kurt and Dirk Hackenberger, Claryx is based in New York and live across multiple health systems. | $3.5M / Pre-Seed / Aug 04, 2026 | |
Prosper AI
|
Prosper's AI Agents handle calls to payors and patients with human-like expertise while cutting costs by over 50%. Whether it’s claims status checks, benefit verification, prior authorizations, patient scheduling, or balance reminders, our agents are always on call - literally. Our bigger goal? To wipe out $200B in admin waste, freeinghealthcare to focus on what it does best—healing, not holding. | $30M / Series A / Jun 22, 2026 | |
Kubera Health
|
Kubera Health is a healthcare technology company that develops an AI-native platform focused on financial performance management across payor-provider relationships. The company builds software that translates healthcare contracts into structured, computable rules and connects them directly to claims and payment data. Its platform providescontinuous monitoring of reimbursement activity, enabling organizations to compare expected payments against actual payments and identify variances. Kubera Health also supports contract modeling and scenario analysis to help healthcare organizations evaluate the financial impact of rate changes and policy adjustments. The system is designed to improve visibility into complex contracting arrangements by centralizing agreement terms, fee schedules, and payment logic into a unified data model. In addition, Kubera Health offers analytics and workflow tools that support negotiation, revenue integrity, and contract performance tracking across healthcare organizations. | $6.5M / Seed / May 28, 2026 | |
UnityAI
|
UnityAI uses AI to enhance the management of hospital beds, optimize resource allocation, and elevate the quality of patient care. | $15M / Series A / Mar 04, 2026 | |
Chamber Cardio
|
Chamber Cardio is a healthcare platform enhances cardiovascular health services offering panel management, financial metrics, clinical data, software support, and value-based contracting, enabling patients and healthcare sectors to receive appropriate treatment. | $60M / Series A / Feb 04, 2026 | |
Formulary Financial
|
Formulary Financial designs tools that enhance financial decision-making, streamline workflows, and optimize portfolio oversight for institutional clients. Its technology applies machine learning to improve the accuracy and efficiency of financial processes while maintaining compliance with industry standards. | $4.6M / Seed / Jan 20, 2026 | |
Kraken
|
Kraken is a cryptocurrency exchange that provides spot and futures trading between Bitcoin, Ethereum, and 40+ other digital assets. Its mission is to accelerate the adoption of cryptocurrency so that you and the rest of the world can achieve financial freedom and inclusion. Founded in 2011 and with over 7 million clients, Kraken is one of theworld's largest, most successful bitcoin exchanges and we're growing faster than ever. Kraken's range of successful products is playing an important role in the mainstream adoption of crypto assets. Kraken is a marketplace for digital assets where buyers, sellers, traders, and speculators come together to exchange cryptocurrencies like Bitcoin, Ethereum, Litecoin, and Ripple against national currencies like USD, EUR, CAD, and JPY. Clients trading larger sizes benefit from its principal Over-the-Counter (OTC) desk and white glove service. Advanced traders and technical analysis wizards can take advantage of the company's professional charting tools. Software engineers, botters, and hobbyist automators have available both REST and Websocket APIs with which trades can be made and market information obtained. Kraken provides 24/7 live chat support for any questions you have about getting started. | $800M / Venture - Series Unknown / Nov 18, 2025 | |
2nd Set AI
|
2nd Set AI is a company that provides AI solutions for enterprises looking to deploy generative images and video to enhance creativity. | Pre-Seed / Aug 13, 2025 | |
Juniper Genomics
|
Juniper Genomics brings modern genomics and data science to those trying to conceive to help overcome barriers and challenges facing IVF patients. | $4.6M / Seed / Jun 26, 2025 | |
Mango
|
Mango is a software firm offering platform to test quality control in biomanufacturing industry. | Series A / May 16, 2025 | |
| See all 182 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Company Ventures invest in?
Company Ventures invests primarily in Software, Health Care and Artificial Intelligence startups, most often at Seed and Series A stage. Most of the 182 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Company Ventures?
Public channels for Company Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Company Ventures?
The team at Company Ventures includes James Lovey (VP, Investments & Operations), Matthew Harrigan (Co-Founder, CEO & Managing Director) and Nelson Schubart (General Partner), among 6 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
